Genenta Science S.p.A. · Biotech

GNTA

Low riskNext report: Not enough history

The short version

A company. Institutions are trimming.

No insider buying or selling in the last 30 days
Institutions cut 30% from their holdings in the quarter ending June 2026 (3 bought, 7 sold)

Facts from SEC filings, not a recommendation.

Price

Price chart by TradingView.

Last 90 days

No open-market insider buys or sells in the last 90 days.

Weekly insider trend

No trades to chart yet.

Last 7 days vs normal

80/ 100

SEC filings of any kind. 50 means a normal week.

Distributing-30.4%

Institutions cut 30.4% from their holdings. 3 bought, 7 sold. 2 quarters of net selling in a row.

Shares held by institutions721K

Sep '24Jun '26

From SEC filings

Share count growthYearly rate, last 3 years

+8.7%

Shares outstandingLatest reported

23M

Why low risk

Last 0

Next reportNot enough history

Offerings 6 months, flags 12 months, holders 90 days

Open-market buys and sells, last 90 days

No open-market buys or sells in 90 days. Grants and option exercises are left out.

"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.

Straight from SEC EDGAR

Source: SEC EDGAR filings. For informational purposes. Not investment advice.